fashion -WSS

fashion

author：explore 2025-10-02 21:36:00 - browse：8538

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Medical records are filled with copy
Next article： Report captures long Covid’s disabling effects and policy challenges

WSS

Awakening the world to the whoosh: A patient's crusade

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

DeSantis talks Trump, trans issues and 'what wokeness is'

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

'Essentially witchcraft:' A former naturopath takes on the field

Teladoc has a new CEO, but challenges remain the same

entertainment

fashion

leisure time

Medicare details structure of new drug price negotiation program

Why Congress must ban federal programs from using QALYs

Drug repurposing or repositioning? The language matters

Cheap, fast test for Zika and dengue could cost just $1

Affirmative action in medical school literally saved lives

Coercive sterilizations revealed by STAT prompt outrage

How one medical school became remarkably diverse

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Walensky prepares to leave CDC — and Congress — behind

Hospitals struggle to profit from CAR

focus

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Tocagen's brain cancer gene therapy trial continues. Investors worry

Cheap, fast test for Zika and dengue could cost just $1

Awakening the world to the whoosh: A patient's crusade

Stanford president's case begs question: Who takes blame?

NIH tests clinical research in primary care with $30 million program

entertainment

leisure time

hotspot

Wikipedia